# NV-001 in the Treatment of Advanced Solid Tumors

> **NCT06051760** · PHASE1 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 20 (estimated)

## Conditions studied

- Malignant Neoplasm

## Interventions

- **BIOLOGICAL:** NV-001

## Key facts

- **NCT ID:** NCT06051760
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06051760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06051760, "NV-001 in the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06051760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*